Tissot, Claire <br/><br/>
Clinical characteristics and outcome of patients with lung cancer harboring BRAF mutations.  [electronic resource] 

 -  Lung cancer (Amsterdam, Netherlands)  Jan 2016 
 - 23-8 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1872-8332 
<br/><br/><label>Standard No.: </label>10.1016/j.lungcan.2015.11.006  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Case-Control Studies<br/>Class I Phosphatidylinositol 3-Kinases<br/>ErbB Receptors--genetics<br/>Female<br/>Genotype<br/>Humans<br/>Imidazoles--therapeutic use<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Mutation<br/>Oximes--therapeutic use<br/>Phosphatidylinositol 3-Kinases--genetics<br/>Prognosis<br/>Protein Kinase Inhibitors--therapeutic use<br/>Proto-Oncogene Proteins B-raf--antagonists & inhibitors<br/>Proto-Oncogene Proteins p21(ras)--genetics<br/>Survival Analysis